Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-2-12
|
pubmed:abstractText |
We investigated the renal and humoral effects of short-term administration of ibopamine, an orally active dopamine agonist, in patients with liver cirrhosis. The patients were divided into two groups on the basis of sodium excretion with a constant sodium intake of 40 mEq/d. We also compared the effects of ibopamine with those induced by intravenous infusion of dopamine hydrochloride (3 micrograms/kg per minute) in similar patients. Ibopamine caused significant increases in urine output, glomerular filtration rate, and sodium excretion throughout the 4 hours of the trial in patients with basal sodium excretion rate greater than 20 mmol/d. These renal effects were associated with a significant reduction in plasma aldosterone concentration. In contrast, only a transient increase in glomerular filtration rate and a diminution in plasma aldosterone concentration were observed after ibopamine in the patients with a basal sodium excretion rate less than 20 mmol/d. The infusion of dopamine had renal effects similar to those of ibopamine in both groups of patients. These results indicate that in cirrhotic patients with normal sodium excretion, ibopamine exerts a diuretic and natriuretic effect similar to that of dopamine infusion. However, these properties of dopaminergic agents are apparently lost in patients with avid sodium retention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/ibopamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0003-9926
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
150
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1967522-Adult,
pubmed-meshheading:1967522-Aged,
pubmed-meshheading:1967522-Aldosterone,
pubmed-meshheading:1967522-Deoxyepinephrine,
pubmed-meshheading:1967522-Diuretics,
pubmed-meshheading:1967522-Dopamine,
pubmed-meshheading:1967522-Dopamine Agents,
pubmed-meshheading:1967522-Glomerular Filtration Rate,
pubmed-meshheading:1967522-Humans,
pubmed-meshheading:1967522-Kidney,
pubmed-meshheading:1967522-Liver Cirrhosis,
pubmed-meshheading:1967522-Male,
pubmed-meshheading:1967522-Middle Aged,
pubmed-meshheading:1967522-Natriuresis,
pubmed-meshheading:1967522-Renin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
|
pubmed:affiliation |
Institute of Internal Medicine, University of Milan Medical School, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|